Biotech

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Endometrial cancer data on Genmab’s Elahere rival beat forecast

The biotech reported a 50% unconfirmed response rate, beating the expectations of analysts to boost confidence ahead of a move into phase 3.
Nick Paul Taylor May 23, 2025 9:22am
Paraglider over Lake Tahoe

Weight of market pressures pushes Novo CEO out—Chutes & Ladders

May 23, 2025 8:30am
GettyImages-1282123802 - 956x537png

Built for the Journey: How Bridge Bank Builds Long-Term Banking Relationships in Life Sciences

May 19, 2025 9:00am
Businessman climbing steps to pluck a star from the sky

Merus hails 'unprecedented' survival on solid tumor bispecific

May 23, 2025 7:35am
AGC Bio

A Smarter Path to Faster, More Reliable Outsourcing Outcomes

May 19, 2025 8:00am
time minute

Innate says lymphoma data shows anti-KIR3DL2 antibody’s promise

May 23, 2025 5:13am